Order genetic test kits

Request free* RPE65 genetic test kits

Biallelic RPE65 gene mutations, the only mutations for which LUXTURNA is indicated, must be confirmed with a genetic test. In order for patients receive to treatment, it must also be confirmed that the patient has viable retinal cells.1

Photographs are not of actual patients.

Before ordering, determine if your patients may be candidates for this RPE65 genetic test

ID APPROPRIATE PATIENTS

Complete the fields below to place your order. You may only order a total of 4 kits at a time. Please note that these kits test only for biallelic RPE65 gene mutations.

Healthcare professional first name
Healthcare professional last name
Street address 1
Street address 2 (optional)
City
State

Select

Zip code
Institution name (optional)
Email address
Phone number
NPI number

I have identified eligible patients for RPE65
genetic test kits and would like to order:

You may only order a total of 4 kits.

Sorry, we didn’t recognize that code please try again

Total ordered = 

0 kits

Please select 1-4 kits

I certify that I am a healthcare professional.

Terms of Use Agreement (optional)

I authorize Spark Therapeutics, Inc., and companies working with Spark, to contact me directly, or by mail, email, and telephone for marketing purposes or to otherwise provide me with information about Spark’s products, services, and programs or other topics of interest, conduct market research or otherwise ask me about my experience with or thoughts about such topics. I understand and agree that any information that I provide may be used by Spark to help develop new products, services, and programs. I understand that my consent is not required as a condition of purchasing or receiving any goods or services from Spark. I understand that I may revoke this authorization and choose not to receive information from Spark by clicking the “unsubscribe” link provided in emails I receive from Spark. I have read and understand the Privacy Policy.

Please note that any test kit ordered through a previous Spark® Therapeutics testing initiative that is not submitted before 1/31/2018 must be accompanied by a new consent form and test requisition form, available here.

*Participation in the test is subject to the Terms and Conditions.